Innoviva, Inc.
US ˙ NasdaqGS ˙ US45781M1018

SecurityINVA / Innoviva, Inc.
InstitutionDimensional Fund Advisors Lp
Latest Disclosed Ownership4,360,401 shares
Ownership 5.80%
Dimensional Fund Advisors Lp ownership in INVA / Innoviva, Inc.

2026-01-21 - Dimensional Fund Advisors Lp has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,360,401 shares of Innoviva, Inc. (US:INVA). This represents 5.8 percent ownership of the company. In their previous filing dated 2024-02-09 , Dimensional Fund Advisors Lp had reported owning 4,516,999 shares, indicating a decrease of -3.47 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2026-01-21 2026-01-21 13G/A 4,516,999 4,360,401 -3.47 5.80 -17.14
2024-02-09 2024-02-09 13G 4,516,999 7.00

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F INNOVIVA COM 45781M101 4,436,427 76,026 1.74 103,366 18.59 0.0215
2026-02-12 2025-12-31 13F INNOVIVA COM 45781M101 4,360,401 30,048 0.69 87,164 10.29 0.0183
2025-11-12 2025-09-30 13F INNOVIVA COM 45781M101 4,330,353 35,960 0.84 79,034 -8.39 0.0170
2025-08-12 2025-06-30 13F INNOVIVA COM 45781M101 4,294,393 -365,397 -7.84 86,274 2.12 0.0200
2025-05-13 2025-03-31 13F INNOVIVA COM 45781M101 4,659,790 -259,728 -5.28 84,482 -1.02 0.0210
2025-02-13 2024-12-31 13F INNOVIVA COM 45781M101 4,919,518 226,592 4.83 85,354 -5.81 0.0205
2024-11-07 2024-09-30 13F INNOVIVA COM 45781M101 4,692,926 8,332 0.18 90,621 17.95 0.0220
2024-08-09 2024-06-30 13F INNOVIVA COM 45781M101 4,684,594 71,336 1.55 76,826 9.27 0.0201
2024-05-10 2024-03-31 13F INNOVIVA COM 45781M101 4,613,258 4,569,113 10,350.24 70,306 39,397.75 0.0190
2024-02-07 2023-12-31 13F THESEUS PHARMACEUTICALS COM 88369M101 44,145 -2,008 -4.35 179 43.55 0.0001
2024-02-07 2023-12-31 13F INNOVIVA COM 45781M101 4,516,999 66,295 72,454 0.0045
2023-11-09 2023-09-30 13F THESEUS PHARMACEUTICALS COM 88369M101 46,153 -32,840 -41.57 124 -83.18 0.0000
2023-11-09 2023-09-30 13F INNOVIVA COM 45781M101 4,450,704 269,197 57,816 0.0190
2023-08-09 2023-06-30 13F THESEUS PHARMACEUTICALS COM 88369M101 78,993 -3,703,211 -97.91 737 -98.27 0.0002
2023-08-09 2023-06-30 13F INNOVIVA COM 45781M101 4,181,507 399,303 53,231 0.0170
2023-05-12 2023-03-31 13F INNOVIVA COM 45781M101 3,782,204 575,010 17.93 42,549 101,207.14 0.0143
2023-02-09 2022-12-31 13F INNOVIVA COM 45781M101 3,207,194 271,075 9.23 42 -99.88 0.0126
2022-11-10 2022-09-30 13F INNOVIVA COM 45781M101 2,936,119 237,843 8.81 34,091 -14.40 0.0131
2022-08-12 2022-06-30 13F INNOVIVA COM 45781M101 2,698,276 157,882 6.21 39,827 -18.98 0.0143
2022-05-13 2022-03-31 13F INNOVIVA COM 45781M101 2,540,394 7,052 0.28 49,156 12.48 0.0151
2022-02-09 2021-12-31 13F INNOVIVA COM 45781M101 2,533,342 -1,353 -0.05 43,701 3.17 0.0132
2021-11-12 2021-09-30 13F INNOVIVA COM 45781M101 2,534,695 72,372 2.94 42,359 28.29 0.0136
2021-08-12 2021-06-30 13F INNOVIVA COM 45781M101 2,462,323 142,265 6.13 33,019 19.10 0.0105
2021-05-14 2021-03-31 13F INNOVIVA COM 45781M101 2,320,058 -32,569 -1.38 27,724 -4.89 0.0092
2021-03-08 2020-12-31 13F/A-2 INNOVIVA COM 45781M101 2,352,627 -5,140 -0.22 29,148 18.31 0.0105
2021-02-11 2020-12-31 13F INNOVIVA COM 45781M101 2,352,627 -5,140 29,148 10,526.7083
2020-11-12 2020-09-30 13F INNOVIVA COM 45781M101 2,357,767 20,846 0.89 24,637 -24.59 0.0104
2020-08-13 2020-06-30 13F INNOVIVA COM 45781M101 2,336,921 77,908 3.45 32,671 22.99 0.0144
2020-05-14 2020-03-31 13F INNOVIVA COM 45781M101 2,259,013 -152,623 -6.33 26,564 -22.21 0.0138
2020-02-14 2019-12-31 13F INNOVIVA COM 45781M101 2,411,636 -229,258 -8.68 34,149 22.69 0.0124
2019-11-12 2019-09-30 13F INNOVIVA COM 45781M101 2,640,894 19,386 0.74 27,834 -27.08 0.0108
2019-08-13 2019-06-30 13F INNOVIVA COM 45781M101 2,621,508 68,292 2.67 38,168 6.55 0.0148
2019-08-12 2019-03-31 13F/A-2 INNOVIVA COM 45781M101 2,553,216 220,799 9.47 35,822 -11.99 0.0143
2019-05-10 2019-03-31 13F INNOVIVA COM 45781M101 2,553,216 220,799 35,822
2019-02-26 2018-12-31 13F/A-1 INNOVIVA COM 45781M101 2,332,417 190,568 8.90 40,700 24.69 0.0184
2019-02-13 2018-12-31 13F INNOVIVA COM 45781M101 2,332,417 190,568 40,700
2018-11-13 2018-09-30 13F INNOVIVA COM 45781M101 2,141,849 232,738 12.19 32,642 23.90 0.0124
2018-08-10 2018-06-30 13F INNOVIVA COM 45781M101 1,909,111 185,825 10.78 26,346 -8.29 0.0105
2018-05-11 2018-03-31 13F INNOVIVA COM 45781M101 1,723,286 426,055 32.84 28,727 56.06 0.0120
2018-02-12 2017-12-31 13F INNOVIVA COM 45781M101 1,297,231 315,377 32.12 18,408 32.78 0.0076
2017-11-13 2017-09-30 13F INNOVIVA COM 45781M101 981,854 179,860 22.43 13,864 35.05 0.0061
2017-08-11 2017-06-30 13F INNOVIVA COM 45781M101 801,994 695,272 651.48 10,266 595.53 0.0047
2017-05-12 2017-03-31 13F INNOVIVA COM 45781M101 106,722 0 0.00 1,476 29.25 0.0007
2017-02-09 2016-12-31 13F INNOVIVA COM 45781M101 106,722 53,731 101.40 1,142 96.22 0.0006
2016-11-10 2016-09-30 13F INNOVIVA COM 45781M101 52,991 11,500 27.72 582 33.18 0.0003
2016-08-09 2016-06-30 13F INNOVIVA COM 45781M101 41,491 41,491 437 0.0003
2015-05-14 2015-03-31 13F THERAVANCE COM 88338T104 0 -2,545 -100.00 0 -100.00
2015-02-06 2014-12-31 13F THERAVANCE COM 88338T104 2,545 -3,465 -57.65 36 -65.05 0.0000
2014-11-13 2014-09-30 13F THERAVANCE COM 88338T104 6,010 -94,898 -94.04 103 -96.57 0.0001
2014-08-08 2014-06-30 13F THERAVANCE COM 88338T104 100,908 -1,225 -1.20 3,006 -4.84 0.0021
2014-05-14 2014-03-31 13F THERAVANCE COM 88338T104 102,133 487 0.48 3,159 -12.78 0.0024
2014-02-12 2013-12-31 13F THERAVANCE COM 88338T104 101,646 -3,041 -2.90 3,622 -15.39 0.0028
2013-11-13 2013-09-30 13F THERAVANCE COM 88338T104 104,687 32,185 44.39 4,281 53.17 0.0037
2013-08-15 2013-06-30 13F THERAVANCE COM 88338T104 72,502 72,502 2,795 0.0026
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.